A key focus of research on pancreatic ductal adenocarcinoma (PDAC) is identifying new techniques to tailor gemcitabine and 5-fluorouracil treatments. Availability of tumor tissue is critical for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback